FAUCI DIARY ARCHIVE — Monday, November 21, 2022
https://faucisdiary.com/diary/2022-11-21

Text below is verbatim from the released PDFs, with the original line breaks.
==============================================================================

DIARY ENTRY — Monday, November 21, 2022
Source: Tony's Diary Package, pp. 1121–1122 of 2026.07.24_Tonys-Diary-Package.pdf
Words: 136
------------------------------------------------------------------------------
Presentation by the Shionogi (Takeki Uehara) Phase 3 data. The drug is an anti-viral
similar to Paxlovid. The data were not particularly impressive since the study was done on
people with very few symptoms and all the drug did was diminished by 24 to at the most 48
hours the duration of the symptoms. The study was not designed to determine whether or not the
drug prevents the need for hospitalization than people with a high risk of severe outcome. All in

all I was not impressed with the data because they were looking at the wrong population of
patients.

PRESS:Pocast for LGBTQ+ community with Avi Ravinath; NFID Podcast with Bill
Shaffner and Marla Dalton; Interview with “Popular Science”; Sheryl Gay Stolberg (NY
Times) came to my house tonight to do an exit interview with photgrapher